英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
cour查看　cour　在百度字典中的解释百度英翻中〔查看〕
cour查看　cour　在Google字典中的解释Google英翻中〔查看〕
cour查看　cour　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Coursera | Courses, Professional Certificates, and Degrees Online
    Learn in-demand skills with online courses and Professional Certificates from leading companies like Google, IBM, Meta, and Adobe Explore flexible programs—from short courses to full degrees
  • Reprogramming the immune system. Restoring lives. | COUR Pharma
    Reprogramming the immune system Restoring lives At COUR, we develop targeted therapies that incite calm within the immune system and help restore the health of people suffering from autoimmune diseases
  • About us | COUR Pharma
    COUR’s scientific and medical advisors bring unique perspectives and expertise to drive the strategic direction and success for potentially life-changing technology
  • California
    Online Case Records and Traffic Payments: Click the link below to search public case information, make a traffic payment, justice partner access, and attorney of record access Pu
  • Cour gets $105M, pharma help to ‘reprogram’ autoimmune disease
    Biotechnology startup Cour Pharmaceuticals has raised $105 million to advance a portfolio of medicines for autoimmune diseases The startup’s funding was co-led by Alpha Wave Ventures and Lumira Ventures and involved large drugmakers Roche, Pfizer and Bristol Myers Squibb
  • Cour inks $940M-plus autoimmune deal with Roches Genentech
    Roche’s Genentech unit has tapped Cour to help develop and commercialize the biotech’s bespoke tolerogenic nanoparticle treatments for autoimmune diseases, Cour said Tuesday
  • News | COUR Pharma
    COUR Pharmaceuticals Secures FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes January 15, 2025 | In the News Liver Disease News: Cour’s CNP-104 granted FDA orphan drug status for treating PBC January 8, 2025 | In the News HCPLive: FDA Grants Orphan Drug Designation to CNP-104 for Primary Biliary Cholangitis 1 2 3 4 5 »
  • Patients | COUR Pharma
    At COUR, we are deeply committed to improving the lives of patients by addressing the root cause of autoimmune diseases, not just by managing symptoms Every milestone we achieve is fueled by the determination and courage of patients who refuse to accept the status quo and seek to push the boundaries of possibility in pursuit of a better future
  • Platform | COUR Pharma
    At COUR, we are transforming the treatment of autoimmune diseases by addressing the root cause: an immune system that has lost the ability to recognize itself Our approach tackles the complexity of autoimmunity at its source, reprogramming upstream to target as many antigens as necessary
  • Careers | COUR Pharma
    At COUR, you’ll have the opportunity to be part of a passionate team that is dedicated to scientific innovation, patient impact, and redefining what’s possible in autoimmune disease treatment





中文字典-英文字典  2005-2009